BioVaxys Technology Corp. (BVAXF)
OTCMKTS · Delayed Price · Currency is USD
0.1159
-0.0027 (-2.28%)
At close: Feb 11, 2026
BioVaxys Technology Market Cap
BioVaxys Technology has a market cap or net worth of $4.7 million as of February 12, 2026. Its market cap has decreased by -58.78% in one year.
Market Cap
4.70M
Enterprise Value
4.80M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.12
Market Cap Chart
Since October 6, 2020, BioVaxys Technology's market cap has decreased from 20.38M to 4.70M, a decrease of -76.91%. That is a compound annual growth rate of -23.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 12, 2026 | 3.88M | -45.14% |
| Dec 31, 2025 | 7.08M | -38.22% |
| Dec 31, 2024 | 11.45M | 108.44% |
| Dec 29, 2023 | 5.49M | -46.60% |
| Dec 30, 2022 | 10.29M | -31.16% |
| Dec 31, 2021 | 14.94M | 33.01% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 6, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Synlogic | 7.25M |
| LakeShore Biopharma | 6.63M |
| BetterLife Pharma | 6.49M |
| Brainstorm Cell Therapeutics | 5.96M |
| Orgenesis | 5.90M |
| GPL Holdings | 5.83M |
| AXIM Biotechnologies | 5.12M |
| Enzon Pharmaceuticals | 5.01M |